Ångstrom Pharmaceuticals, Inc.
Ångstrom Pharmaceuticals, Inc. is a venture-backed pharmaceutical company. Ångstrom’s proprietary products target a clearly-defined pathway, the Urokinase Plasminogen Activation System (PA), which...
www.angstrominc.com/ View full profile
| |
AnorMED Inc.
AnorMED was founded in 1996 and listed on the TSX as “AOM” in 1999 and on the AMEX as "AOM" in 2005. To date, the Company has raised over $160 million to support its research and development programs....
www.anormed.com/ View full profile
| |
ANTISENSE PHARMA GmbH
ANTISENSE PHARMA is an innovative biotech company aimed at developing and marketing novel antisense technology based drugs for the treatment of cancer and other so far incurable diseases.
Founded...
www.antisense-pharma.com/ View full profile
| |
Antisoma plc
Antisoma is a biotechnology company specialising in the development of novel anti-cancer drugs. The Company was founded in 1988, and its shares are traded on the London Stock Exchange.
Antisoma...
www.antisoma.co.uk/ View full profile
| |
Antisoma plc
Antisoma is a biotechnology company specialising in the development of novel anti-cancer drugs. The Company was founded in 1988, and its shares are traded on the London Stock Exchange.
Antisoma...
www.antisoma.com/ View full profile
| |
Aphton Corporation
Aphton Corporation, headquartered in Philadelphia, Pennsylvania , is a clinical stage biopharmaceutical company focused on developing targeted immunotherapies for cancer. Aphton's products seek to...
www.aphton.com/ View full profile
| |
Apogenix GmbH
The biopharmaceutical company Apogenix, located in Heidelberg, Germany, develops innovative drug candidates which exert their therapeutic effect by modulating the programmed cell death (apoptosis)....
www.apogenix.com/ View full profile
| |
Applied Gene Technologies
Applied Gene Technologies, a San Diego, California company plans to develop, manufacture and market biopharmaceutical products based on patented Tessera Array Technology™ (TAT). Initial focus of the...
www.appliedgene.com/ View full profile
| |
Aptium Oncology
For over 20 years Aptium Oncology has been working with hospitals and physicians to develop centers designed to accommodate the future of cancer care. From conception to development to management, the...
www.aptiumoncology.com/ View full profile
| |
Aranesp
Aranesp® (darbepoetin alfa) is indicated for the treatment of anemia associated with chronic renal failure (CRF), including patients on dialysis and patients not on dialysis, and for the treatment of...
www.aranesp.com/ View full profile
| |
Arbor Vita Corporation.
Arbor Vita is a biopharmaceutical company focused on the discovery, development and commercialization of novel drugs and diagnostics addressing disease through a new family of targets, PDZ proteins....
www.arborvita.com/ View full profile
| |
ARIUS Research Inc.
ARIUS Research Inc. is a biotechnology company dedicated to personalizing cancer therapy through the discovery and development of novel anticancer monoclonal antibodies (MAbs). Established in 1999,...
www.ARIUSRESEARCH.COM/ View full profile
| |
Dr.Stephan Ariyan
Dr. Stephan Ariyan is a Clinical Professor of Surgery, Plastic Surgery, and Otolaryngology at Yale University School of Medicine and Director, Yale Cancer Center Melanoma Unit. He was Professor and...
www.ariyan.com/ View full profile
| |
Ark Therapeutics Ltd
Ark Therapeutics is a specialist healthcare group with operations in the UK and Finland. Ark focuses on areas of high unmet clinical need in vascular disease and cancer, where opportunities exist for...
www.arktherapeutics.com/ View full profile
| |
Cosmetic Procedures & Services Patient Information
Dr. Anthony V. Benedetto after completing his internship, residency and surgical training at the Cleveland Clinic in Ohio, returned to Philadelphia in 1978 to begin his practice in dermatologic...
www.benedettoderm.com/ View full profile
| |
